Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 2536 AL 2550

Canadian Guidelines on Parkinson's Disease

Grimes D, Gordon J, Snelgrove B, Lim-Carter I, Fon E, Martin W, Wieler M, Suchowersky O, Rajput A, Lafontaine AL, Stoessl J, Moro E, Schoffer K, Miyasaki J, Hobson D, Mahmoudi M, Fox S, Postuma R, Kumar H, Jog M; Canadian Nourological Sciences Federation.

Can J Neurol Sci. 2012 Jul;39(4 Suppl 4):S1-30. doi: 10.1017/s031716710001516x.

Leucine-rich repeat kinase 2 inhibitors: a patent review (2006 - 2011)

Deng X, Choi HG, Buhrlage SJ, Gray NS.

Expert Opin Ther Pat. 2012 Dec;22(12):1415-26. doi: 10.1517/13543776.2012.729041. Epub 2012 Nov 6.

Atrial fibrillation with wide QRS tachycardia and undiagnosed Wolff-Parkinson-White syndrome: diagnostic and therapeutic dilemmas in a pediatric patient

Panduranga P, Al-Farqani A, Al-Rawahi N.

Pediatr Emerg Care. 2012 Nov;28(11):1227-9. doi: 10.1097/PEC.0b013e31827208c5.

In the clinic. Parkinson disease

Chou KL.

Ann Intern Med. 2012 Nov 6;157(9):ITC5-1 - ITC5-16. doi: 10.7326/0003-4819-157-9-201211060-01005.

Peroxisome proliferator-activated receptor-γ cofactors in neurodegeneration

Katsouri L, Blondrath K, Sastre M.

IUBMB Life. 2012 Dec;64(12):958-64. doi: 10.1002/iub.1097. Epub 2012 Nov 6.

Phosphodiesterases in neurodegenerative disorders

Bollen E, Prickaerts J.

IUBMB Life. 2012 Dec;64(12):965-70. doi: 10.1002/iub.1104. Epub 2012 Nov 5.

[New approach to gait disorders therapy in late stages of Parkinson's disease]

Litvinenko IV, Khalimov RR, Trufanov AG, Krasakov IV, Khaĭmov DA.

Adv Gerontol. 2012;25(2):267-74.

Implications of Parkinson's disease pathophysiology for the development of cell replacement strategies and drug discovery in neurodegenerative diseases

Pan-Montojo F, Funk RH.

CNS Neurol Disord Drug Targets. 2012 Nov 1;11(7):907-20. doi: 10.2174/1871527311201070907.

From stem cells to dopamine neurons: developmental biology meets neurodegeneration

Tailor J, Andreska T, Kittappa R.

CNS Neurol Disord Drug Targets. 2012 Nov 1;11(7):893-6. doi: 10.2174/1871527311201070893.

Role of tau protein in neuronal damage in Alzheimer's disease and Down syndrome

Cárdenas AM, Ardiles AO, Barraza N, Baéz-Matus X, Caviedes P.

Arch Med Res. 2012 Nov;43(8):645-54. doi: 10.1016/j.arcmed.2012.10.012. Epub 2012 Nov 7.

The subthalamic microlesion story in Parkinson's disease: electrode insertion-related motor improvement with relative cortico-subcortical hypoactivation in fMRI

Jech R, Mueller K, Urgošík D, Sieger T, Holiga Š, Růžička F, Dušek P, Havránková P, Vymazal J, Růžička E.

PLoS One. 2012;7(11):e49056. doi: 10.1371/journal.pone.0049056. Epub 2012 Nov 7.

Parkinson disease and driving: an evidence-based review

Crizzle AM, Classen S, Uc EY.

Neurology. 2012 Nov 13;79(20):2067-74. doi: 10.1212/WNL.0b013e3182749e95.

Neurodegeneration in Parkinson disease: moving Lewy bodies out of focus

Schulz-Schaeffer WJ.

Neurology. 2012 Dec 11;79(24):2298-9. doi: 10.1212/WNL.0b013e318278b6a7. Epub 2012 Nov 14.

Treatment of recurrent sigmoid volvulus in Parkinson's disease by percutaneous endoscopic colostomy

Toebosch S, Tudyka V, Masclee A, Koek G.

World J Gastroenterol. 2012 Oct 28;18(40):5812-5. doi: 10.3748/wjg.v18.i40.5812.

Optimizing treatment for Parkinson's disease

Schapira AH, Tan EK.

Eur J Neurol. 2012 Dec;19(12):1483-6. doi: 10.1111/ene.12025.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias